Release Date: 29/05/18 09:43 Summary: OHE Updates on Strategic Review, Delivers FY18 Results Price Sensitive: Yes Download Document 204.96KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status